ProSolus doubles transdermal patch capacity with new Texas facility

ProSolus Pharmaceuticals, owned by Mission Pharmacal, opened a new transdermal patch manufacturing facility in Boerne, Texas, more than doubling its capacity to up to 100 million patches per year. The company already has a facility in Miami, Florida.

“ProSolus, which already has a transdermal patch manufacturing facility in Florida, has opened a larger plant in Texas.”fiercepharma.com

• 1 source
• fiercepharma.comTransdermal patch manufacturer ProSolus doubles capacity with Texas facility | Fierce PharmaEric PalmerMay 4, 2017

Summarized from public sources; check the original articles before acting on it.